NDC properties for "Tobradex (tobramycin 0.3 % / dexamethasone 0.1 % ) Ophthalmic Ointment" (RxCUI 208821)
About this data
The tables show NDC propoerties for Tobradex (tobramycin 0.3 % / dexamethasone 0.1 % ) Ophthalmic Ointment with the RxCUI 208821
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Tobradex (tobramycin 0.3 % / dexamethasone 0.1 % ) Ophthalmic Ointment (RxCUI 208821)
MMSL_CODE | BD3436 |
---|---|
NDA | NDA050616 |
RxCUI | 208821 |
SPL_SET_ID | 7f310e0e-0d3b-493d-b6c4-238493a2a9b9 |
SPL_SET_ID | fe08bcd5-4d14-4c2d-940c-b7968f9a89f0 |
Prescribable Synonym | TobraDex 0.3 % / 0.1 % Ophthalmic Ointment |
RXNAV_STR | Tobradex (tobramycin 0.3 % / dexAMETHasone 0.1 % ) Ophthalmic Ointment |
RxNorm Name | dexamethasone 0.001 MG/MG / tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobradex] |
RxNorm Synonym | Tobradex (tobramycin 0.3 % / dexamethasone 0.1 % ) Ophthalmic Ointment |
Tallman Synonym | dexAMETHasone 0.001 MG/MG / tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobradex] |
Tallman Synonym | Tobradex (tobramycin 0.3 % / dexAMETHasone 0.1 % ) Ophthalmic Ointment |
Related queries | Interactions (for RxCUI 208821) |
NDC Properties
NDC Item 00065064835
NDC 9 | 0065-0648 |
---|---|
NDC 10 | 0065-0648-35 |
NDC Item | 00065064835 |
Packaging | 1 TUBE in 1 CARTON (0065-0648-35) / 3.5 g in 1 TUBE |
FDA SPL set id | 587764 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2022-06-30 |
Marketing effective time low | 1988-10-15 |
Marketing status | COMPLETED |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0065-0648 |
NDC Item 00078087601
NDC 9 | 0078-0876 |
---|---|
NDC 10 | 0078-0876-01 |
NDC Item | 00078087601 |
Packaging | 3.5 g in 1 TUBE (0078-0876-01) |
FDA SPL set id | 861876 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1988-10-15 |
Marketing status | ACTIVE |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0078-0876 |
NDC Item 00780087601
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00780087601 |
Related queries | Properties for NDC 9 |
NDC Item 52959059203
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959059203 |
Related queries | Properties for NDC 9 |
NDC Item 00065064835
NDC 9 | 0065-0648 |
---|---|
NDC 10 | 0065-0648-35 |
NDC Item | 00065064835 |
Packaging | 1 TUBE in 1 CARTON (0065-0648-35) / 3.5 g in 1 TUBE |
FDA SPL set id | 587764 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2022-06-30 |
Marketing effective time low | 1988-10-15 |
Marketing status | COMPLETED |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0065-0648 |
NDC Item 00078087601
NDC 9 | 0078-0876 |
---|---|
NDC 10 | 0078-0876-01 |
NDC Item | 00078087601 |
Packaging | 3.5 g in 1 TUBE (0078-0876-01) |
FDA SPL set id | 861876 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1988-10-15 |
Marketing status | ACTIVE |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0078-0876 |
NDC Item 00780087601
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00780087601 |
Related queries | Properties for NDC 9 |
NDC Item 52959059203
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959059203 |
Related queries | Properties for NDC 9 |
NDC Item 00065064835
NDC 9 | 0065-0648 |
---|---|
NDC 10 | 0065-0648-35 |
NDC Item | 00065064835 |
Packaging | 1 TUBE in 1 CARTON (0065-0648-35) / 3.5 g in 1 TUBE |
FDA SPL set id | 587764 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2022-06-30 |
Marketing effective time low | 1988-10-15 |
Marketing status | COMPLETED |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0065-0648 |
NDC Item 00078087601
NDC 9 | 0078-0876 |
---|---|
NDC 10 | 0078-0876-01 |
NDC Item | 00078087601 |
Packaging | 3.5 g in 1 TUBE (0078-0876-01) |
FDA SPL set id | 861876 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1988-10-15 |
Marketing status | ACTIVE |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0078-0876 |
NDC Item 00780087601
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00780087601 |
Related queries | Properties for NDC 9 |
NDC Item 52959059203
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959059203 |
Related queries | Properties for NDC 9 |
NDC Item 00065064835
NDC 9 | 0065-0648 |
---|---|
NDC 10 | 0065-0648-35 |
NDC Item | 00065064835 |
Packaging | 1 TUBE in 1 CARTON (0065-0648-35) / 3.5 g in 1 TUBE |
FDA SPL set id | 587764 |
Labeler | Alcon Laboratories, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time high | 2022-06-30 |
Marketing effective time low | 1988-10-15 |
Marketing status | COMPLETED |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0065-0648 |
NDC Item 00078087601
NDC 9 | 0078-0876 |
---|---|
NDC 10 | 0078-0876-01 |
NDC Item | 00078087601 |
Packaging | 3.5 g in 1 TUBE (0078-0876-01) |
FDA SPL set id | 861876 |
Labeler | Novartis Pharmaceuticals Corporation |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 1988-10-15 |
Marketing status | ACTIVE |
NDA | NDA050616 |
Related queries | Properties for NDC 9 0078-0876 |
NDC Item 00780087601
NDC 10 | UNKNOWN |
---|---|
NDC Item | 00780087601 |
Related queries | Properties for NDC 9 |
NDC Item 52959059203
NDC 10 | UNKNOWN |
---|---|
NDC Item | 52959059203 |
Related queries | Properties for NDC 9 |